Patents by Inventor Sean Andrew Parsons

Sean Andrew Parsons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150241455
    Abstract: Apparatus is disclosed for identifying at least a first target condition in a human or animal body. The apparatus comprises one or more test portions for identifying a first analyte in a biological sample from the body, the first analyte providing a marker of the first target condition, and a second analyte in the biological sample, the second analyte being different from the first analyte. The apparatus is configured to identify the first target condition in the body based on the identification of both the first and second analytes. In one embodiment, the first target condition is pregnancy, the first analyte is human chorionic gonadotropin (hCG) and the second analyte is luteinizing hormone (LH).
    Type: Application
    Filed: September 27, 2013
    Publication date: August 27, 2015
    Applicant: Ellume Pty Ltd
    Inventor: Sean Andrew Parsons
  • Publication number: 20150204891
    Abstract: Apparatus is disclosed for identifying at least a first target condition in a human or animal body. The apparatus comprises one or more test portions for identifying a first analyte in a biological sample from the body, the first analyte providing a marker of the first target condition, and a second analyte in the biological sample, the second analyte being different from the first analyte. The apparatus is configured to identify the first target condition in the body based on the identification of both the first and second analytes. In one embodiment, the first target condition is pregnancy, the first analyte is human chorionic gonadotropin (hCG) and the second analyte is luteinizing hormone (LH).
    Type: Application
    Filed: March 30, 2015
    Publication date: July 23, 2015
    Applicant: Ellume Pty Ltd
    Inventor: SEAN ANDREW PARSONS
  • Publication number: 20140296667
    Abstract: A device (1) is provided that is configured to indicate the presence or absence of one or more biological entities in a biological sample. The device comprises a sampling portion (11), the sampling portion comprising flexible material adjustably conformable to a part of a human or animal body, at least a portion of the sampling portion being absorbent and configured to receive a biological sample directly from the body; and a test portion (12) in fluid engagement with the sampling portion, the test portion comprising one or more test zones (14). The sampling portion and test portion are configured such that at least a portion of the sample received by the sampling portion is transferable to the test portion such as to contact one or more of the test zones, and wherein each test zone is configured to indicate the presence or absence of one or more biological entities in the sample.
    Type: Application
    Filed: January 27, 2011
    Publication date: October 2, 2014
    Applicant: RESPIRIO PTY LTD
    Inventors: Steven David Dahl, Sean Andrew Parsons, Jennifer Maschmann, Kon Euan Gerard Wong, Tim Ian Spink, Stephen Robert Wilson
  • Publication number: 20130096400
    Abstract: A device (1) is provided that is configured to indicate the presence or absence of one or more biological entities in a biological sample. The device comprises a sampling portion (11), the sampling portion comprising flexible material adjustably conformable to a part of a human or animal body, at least a portion of the sampling portion being absorbent and configured to receive a biological sample directly from the body; and a test portion (12) in fluid engagement with the sampling portion, the test portion comprising one or more test zones (14). The sampling portion and test portion are configured such that at least a portion of the sample received by the sampling portion is transferable to the test portion such as to contact one or more of the test zones, and wherein each test zone is configured to indicate the presence or absence of one or more biological entities in the sample.
    Type: Application
    Filed: January 27, 2011
    Publication date: April 18, 2013
    Applicant: RESPIRIO PTY LTD
    Inventors: Steven David Dahl, Sean Andrew Parsons, Jennifer Maschmann, Kon Euan Gerard Wong, Tim Ian Spink, Stephen Robert Wilson
  • Patent number: D679410
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: April 2, 2013
    Assignee: Respirio Pty Ltd
    Inventors: Sean Andrew Parsons, Steven David Dahl, Jennifer Maschmann, Kon Euan Gerard Wong, Stephen Robert Wilson, Tim Ian Spink